Medicamen Biotech - Quarterly Results
11th Feb 2019

The sales is pegged at Rs. 240.83 millions for the December 2018 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 282.93 millions during the year-ago period.The Net proft of the company remain more or less same to Rs. 24.05  millions from Rs. 28.40 millions ,decline by -15.32%.Operating Profit reported a sharp decline to 44.53 millions from 47.12 millions in the corresponding previous quarter.



(Rs. in Million)


  Quarter ended Year to Date Year ended
  201812 201712 % Var 201812 201712 % Var 201803 201703 % Var
Sales 240.83 282.93 -14.88 893.34 822.06 8.67 1115.07 824.56 35.23
Other Income 0.71 -2.16 -132.87 30.39 8.89 241.84 18.87 3.07 514.66
PBIDT 44.53 47.12 -5.50 157.73 133.59 18.07 183.66 113.13 62.34
Interest 2.03 7.44 -72.72 9.12 18.98 -51.95 24.08 30.32 -20.58
PBDT 42.48 39.69 7.03 148.59 114.62 29.64 159.58 82.81 92.71
Depreciation 5.92 5.63 5.15 15.53 15.59 -0.38 20.58 19.22 7.08
PBT 36.56 34.06 7.34 133.06 99.03 34.36 139.00 63.59 118.59
TAX 12.51 5.67 120.63 41.19 18.79 119.21 37.88 11.99 215.93
Deferred Tax -0.77 -1.74 -55.75 -1.43 -1.86 -23.12 -2.31 -0.98 135.71
PAT 24.05 28.40 -15.32 91.87 80.25 14.48 101.13 51.60 95.99
Equity 117.00 113.76 2.85 117.00 113.76 2.85 117.00 105.19 11.23
PBIDTM(%) 18.48 16.66 10.95 17.66 16.25 8.65 16.47 13.72 20.05